Dexrabeprazole Sodium & Cinitapride Capsules

Acid Control & Prokinetic Combination | Manufacturer & Exporter – Wellona Pharma

Dexrabeprazole Sodium & Cinitapride Capsules are a highly effective combination therapy used in the management of gastroesophageal reflux disease (GERD), acid reflux, functional dyspepsia, and motility disorders. This advanced formulation combines a proton pump inhibitor (Dexrabeprazole Sodium) with a prokinetic agent (Cinitapride) to provide dual action—reducing gastric acid secretion and improving gastrointestinal motility.

Wellona Pharma is a trusted manufacturer and exporter of Dexrabeprazole Sodium & Cinitapride Capsules, supplying high-quality pharmaceutical formulations that comply with international quality standards for global markets.

This synergistic combination ensures faster symptom relief and improved digestive comfort.

Uses of Dexrabeprazole Sodium & Cinitapride Capsules

• Gastroesophageal Reflux Disease (GERD)
• Acid reflux and heartburn
• Functional dyspepsia
• Gastritis and peptic ulcer disease
• Delayed gastric emptying
• Bloating, nausea, and regurgitation
• Acid-related gastrointestinal disorders

Side Effects

• Headache
• Diarrhea or constipation
• Nausea
• Abdominal discomfort
• Dizziness
• Dry mouth

Quality Assurance by Wellona Pharma

• WHO-GMP compliant manufacturing
• Stringent quality control and testing
• Stable and effective formulations
• Available for bulk supply and private labeling

Contact Us

For bulk orders, third-party manufacturing, or export inquiries of Dexrabeprazole Sodium & Cinitapride Capsules, connect with Wellona Pharma, your reliable pharmaceutical manufacturing and exporting partner.